DaVita Inc (DVA)
164.14
+2.74
(+1.70%)
USD |
NYSE |
Nov 21, 16:00
164.85
+0.71
(+0.43%)
Pre-Market: 20:00
DaVita Enterprise Value: 23.76B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 23.76B |
| November 20, 2024 | 23.54B |
| November 19, 2024 | 23.17B |
| November 18, 2024 | 23.21B |
| November 15, 2024 | 23.45B |
| November 14, 2024 | 22.96B |
| November 13, 2024 | 23.20B |
| November 12, 2024 | 23.26B |
| November 11, 2024 | 22.97B |
| November 08, 2024 | 22.57B |
| November 07, 2024 | 22.63B |
| November 06, 2024 | 22.36B |
| November 05, 2024 | 22.36B |
| November 04, 2024 | 22.19B |
| November 01, 2024 | 21.91B |
| October 31, 2024 | 21.77B |
| October 30, 2024 | 21.88B |
| October 29, 2024 | 23.28B |
| October 28, 2024 | 23.18B |
| October 25, 2024 | 23.17B |
| October 24, 2024 | 23.63B |
| October 23, 2024 | 23.75B |
| October 22, 2024 | 23.78B |
| October 21, 2024 | 23.64B |
| October 18, 2024 | 23.68B |
| Date | Value |
|---|---|
| October 17, 2024 | 23.53B |
| October 16, 2024 | 23.92B |
| October 15, 2024 | 23.90B |
| October 14, 2024 | 23.67B |
| October 11, 2024 | 23.59B |
| October 10, 2024 | 23.47B |
| October 09, 2024 | 23.46B |
| October 08, 2024 | 23.05B |
| October 07, 2024 | 23.31B |
| October 04, 2024 | 23.57B |
| October 03, 2024 | 23.44B |
| October 02, 2024 | 23.44B |
| October 01, 2024 | 23.74B |
| September 30, 2024 | 23.84B |
| September 27, 2024 | 24.03B |
| September 26, 2024 | 23.96B |
| September 25, 2024 | 24.11B |
| September 24, 2024 | 23.90B |
| September 23, 2024 | 23.90B |
| September 20, 2024 | 24.10B |
| September 19, 2024 | 24.03B |
| September 18, 2024 | 24.03B |
| September 17, 2024 | 24.12B |
| September 16, 2024 | 24.20B |
| September 13, 2024 | 24.07B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.07B
Minimum
Nov 09 2022
24.20B
Maximum
Sep 16 2024
19.88B
Average
19.32B
Median
Aug 01 2023
Enterprise Value Benchmarks
| Quest Diagnostics Inc | 23.89B |
| Encompass Health Corp | 13.21B |
| HCA Healthcare Inc | 127.20B |
| Baxter International Inc | 28.43B |
| Boston Scientific Corp | 143.48B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 214.69M |
| Revenue (Quarterly) | 3.264B |
| Total Expenses (Quarterly) | 2.732B |
| EPS Diluted (Quarterly) | 2.50 |
| Gross Profit Margin (Quarterly) | 34.06% |
| Profit Margin (Quarterly) | 6.58% |
| Earnings Yield | 5.65% |
| Operating Earnings Yield | 12.83% |
| Normalized Earnings Yield | 5.700 |